Searchable abstracts of presentations at key conferences in endocrinology

ea0017p1 | (1) | BSPED2008

Comparisons of patients with septo optic dysplasia, multiple pituitary hormone deficiency and isolated GH deficiency

Stone E , Kirk J , Mcpherson L

Introduction: Septo optic dysplasia is a triad of conditions, which include MPHD, IGHD and ONH. We have analysed data in our regional cohort primarily focusing on MRI brain scans.Patients and methods: MRI scans of the brain including T1/T2 weighted high resolution images in children with a diagnosis of septo optic dysplasia (SOD (N=38)), multiple pituitary hormone deficiency (MPHD (N=19)) and isolated GH deficiency (IGHD (n=14)) (tot...

ea0017p21 | (1) | BSPED2008

Premature sexual maturation: incidence and aetiology

Stanley S , Stone E , Kirk J

Over the last few years, we have seen increasing numbers of referrals to our regional paediatric endocrine unit with premature sexual maturation (PSM), especially adrenarche and isolated thelarche. Therefore, we audited referrals for PSM over three years, and compared them to published historical data collected over 15 years in another regional paediatric endocrine unit (Bridges et al. 1994).<thead valig...

ea0016p376 | Growth factors | ECE2008

Overexpression of IGFBP-2 in transgenic mice affects muscle protein accretion, skeletal myofibre growth and metabolism

Rehfeldt C , Renne U , Wolf E , Hoflich A

To elucidate the functional role of IGFBP-2 for in vivo skeletal muscle growth and function, skeletal muscle cellularity and metabolism as well as body growth and composition have been studied in a transgenic mouse model overexpressing IGFBP-2. Postnatal growth rate of transgenic mice (n=20) was clearly reduced from day 21 of age by 6–8% (P<0.05) compared with non-transgenic controls (n=37). At the final day of live (day 72 of age) body pro...

ea0014p539 | (1) | ECE2007

Incorporation and release of 3H-norepinephrine by granulosa cells: Novel functionality for endocrine cells

Greiner Monika , Lara Hernán E

Ovarian function in mammals is regulated by gonadotropins and by sympathetic nervous system. Norepinephrine (NE) is one of the major neurotransmitters present in the fibres innervating the gonad and regulates follicular development and ovarian steroids release. Surgical section of the sympathetic fibres partially decreased the release of NE as compared with non-denervated rats. The remnant release capability supposes the existence of an intraovarian compartment able to incorpo...

ea0013p80 | Clinical practice/governance and case reports | SFEBES2007

Hyperchloraemic metabolic acidosis with hypokalaemia and osteomalacia

Gardner Daphne S-L , Flanagan Daniel E

Background: A 52-y-old lady (Mrs M) presented with a 10-day history of progressive generalised weakness, dysarthria and un-coordination. 26 y ago, she had cervical carcinoma, requiring a hysterectomy, oophorectomy and radiotherapy. This led to a vesicovaginal fistula, requiring a cystectomy and ureterosigmoidostomy. She is known to have osteoporosis. Medications: calfovit D3 one/d (started 5 days prior to admission), risedronate, lansoprazole. She had HRT until 50 y. Examinati...

ea0012p12 | Clinical case reports/Governance | SFE2006

Milk-Alkali Syndrome without milk

Kaklamanos M , Lim E , Perros P

IntroductionMilk-Alkali Syndrome is defined by the triad of hypercalcaemia, acute renal failure and metabolic alkalosis. It was first described by Sippy in 1915 after people were treated with the Sippy regimen for peptic ulcer disease.Case reportA 76 year old woman was referred to the Endocrinology Clinic after she was initially presented to the Gastroenterolgy team with altered bowel habits, hypercalcaemia (...

ea0011oc28 | Diabetes and metabolism | ECE2006

11β-Hydroxysteroid dehydrogenase type 1 oxo-reductase activity is increased in patients with alcoholic chronic liver disease: the key to the phenotype of the alcoholic pseudo-Cushing’s state?

Ahmed A , Saksena S , Elias E , Stewart PM

The pseudo-Cushing’s syndrome that accompanies both acute alcohol ingestion and alcohol withdrawal is an important differential diagnosis of hypercortisolism that is poorly understood. Two isozymes of 11β-hydroxysteroid dehydrogenase (11β-HSD) interconvert hormonally active cortisol (F) and inactive cortisone (E). Previously we have shown higher urinary F:E metabolite ratios (a reflection of total body 11βHSD activity) in patients with alcoholic liver disea...

ea0011p177 | Clinical practise and governance | ECE2006

Symptom-specific thresholds for testosterone deficiency modulate complaints and metabolic risk in 434 aging male patients

Zitzmann M , Faber S , Nieschlag E

Objective: The structure of psychological and somatic complaints of aging male patients in relation to sex hormone patterns and metabolism has not been fully elucidated, especially in regard to late-onset hypogonadism.Methods: We investigated the nature of complaints in 434 consecutive patients aged 50–86 years attending our andrology unit and their association with physical characteristics, life style habits and sex hormone levels.<p class="abs...

ea0011p178 | Clinical practise and governance | ECE2006

Longterm experience of more than 8 years with a novel formulation of testosterone undecanoate (Nebido) in substitution therapy of hypogonadal men

Zitzmann M , Saad F , Nieschlag E

Objective: A reliable form of androgen substitution therapy in terms of favorable kinetics and tolerance as well as effective restoration of androgenicity is paramount in hypogonadal men. A feasible modality is the intramuscular injection of the long-acting ester testosterone undecanoate (TU).Design: We report data from 22 patients (15 with primary and 7 with secondary hypogonadism) aged 30 to 65 years (mean 43.8±8 years) who received injections of ...

ea0011p312 | Diabetes, metabolism and cardiovascular | ECE2006

A case of myocardial infarction induced by factitious hypoglycaemia in type 2 diabetes patient

Srinivasan R , Sanders E , Flynn M

Introduction: Insulin is widely used in Type 2 patients to control the blood sugar when the oral hypoglycaemic agents fail. This is a case report of a type 2 diabetes patient who developed Myocardial Infarction after factitious hypoglycaemia with insulin.Case report: A 64-year-old gentleman with known Ischaemic Heart Disease was treated with insulin (Mixtard 30) and metformin for his type 2 diabetes. He presented to diabetes Specialist nurse with persist...